Evaluation of Advanced Glycation End Products, Oxidative Stress and Antioxidants and their Relationship in Diabetic patients

Zahraa Saad Tahseen; Kamaran  Abdoulrahman

doi:10.21271/ZJPAS.35.2.14

Authors

Zahraa Saad Tahseen Department of Chemistry, Faculty of Science and Health, Koya University, Koya KOY45, Kurdistan Region - F.R. Iraq
Kamaran Abdoulrahman Department of Chemistry, College of Science, Salahaddin University-Erbil, Kurdistan Region, Iraq.

DOI:

https://doi.org/10.21271/ZJPAS.35.2.14

Keywords:

Advanced Glycation End products (AGEs), Oxidative Stress (OS), Antioxidants, lipid profile, Diabetes Mellitus (DM)

Abstract

Objective: Diabetes Mellitus (DM) is a major public health problem in developed countries; which also plays a vital role in providing information about advanced glycation end products (AGEs) and these induce oxidative stress (OS). The aim of this study is to evaluate the AGEs, OS, antioxidant, and lipid profile parameters in sera of DM patients.

Methods: The current study includes 82 subjects (50 patients with type II DM and 32 healthy subjects, men and women). Demographic factors and medication intake of every subject were obtained. The advanced glycation end products (AGEs), oxidative stress (OS), antioxidant, and lipid profile parameters were measured using a spectrometric method and ELISA test.

Results: The present study elucidated that the serum levels of CML, CEL, Pyralline, 8-OHdG, and MDA were significantly increased in diabetic patients compared with the healthy group. The serum levels of GSH, NO, and GSH-Px were significantly decreased in patients with DM rather than in the healthy group. While the serum levels of CAT and SOD were non-significantly decreased in patients with DM.

Conclusion: Meanwhile, the elevation of AGEs and OS are associated with DM patients. NO and CML could be potential biomarkers for DM.

References

ABDOULRAHMAN, K. 2017. Lipid profile, oxidative stress and homocysteine in chronic renal failure CRF patients pre- and post-hemodialysis in Erbil city. ZANCO JOURNAL OF PURE AND APPLIED SCIENCES, 29, 65-73.

ABDOULRAHMAN, K. K. 2016. Evaluation of Homocysteine and Some Biochemical Parameters in Patients with Coronary Atherosclerosis in Erbil Governorate. ZANCO Journal of Pure and Applied Sciences, 28, 53-61.

AGUSHAKA, J. O. & EZUGWU, A. E. Diabetes classification techniques: a brief state-of-the-art literature review. International Conference on Applied Informatics, 2020. Springer, 313-329.

AHUJA, P., WARIS, A., SIDDIQUI, S. S. & MUKHERJEE, A. 2022. Single nucleotide variants of receptor for advanced glycation end-products (AGER) gene: is it a new opening in the risk assessment of diabetic retinopathy?—a review. Journal of Genetic Engineering and Biotechnology, 20, 1-15.

AMIRI, I., KARIMI, J., PIRI, H., GOODARZI, M. T., TAVILANI, H., KHODADADI, I. & GHORBANI, M. 2011. Association between nitric oxide and 8-hydroxydeoxyguanosine levels in semen of diabetic men. Systems biology in reproductive medicine, 57, 292-295.

ARPACI, A., YALıN, S., ECEVIT, H., COMELEKOGLU, U. & METE, T. 2020. Enzyme activity and genetic polymorphisms in patients with type II diabetes mellitus. Advances in Clinical and Experimental Medicine, 29, 1057-1063.

ARRIBAS, L., ALMANSA, I., MIRANDA, M., MURIACH, M., ROMERO, F. J. & VILLAR, V. M. 2016. Serum malondialdehyde concentration and glutathione peroxidase activity in a longitudinal study of gestational diabetes. PLoS One, 11, e0155353.

ARTHA, I. M. J. R., BHARGAH, A., DHARMAWAN, N. K., PANDE, U. W., TRIYANA, K. A., MAHARISKI, P. A., YUWONO, J., BHARGAH, V., PRABAWA, I. P. Y. & MANUABA, I. B. A. P. 2019. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus. Vascular Health and Risk Management, 15, 149.

ASGHARPOUR, M. & ALIREZAEI, A. 2021. Herbal antioxidants in dialysis patients: a review of potential mechanisms and medical implications. Renal failure, 43, 351-361.

BALA, C. G., RUSU, A., CIOBANU, D., BUCSA, C. & ROMAN, G. 2021. Amino acid signature of oxidative stress in patients with type 2 diabetes: targeted exploratory metabolomic research. Antioxidants, 10, 610.

BHAMBHANI, G., BHAMBHANI, R. G. & THAKOR, N. C. 2015. Lipid profile of patients with diabetes mellitus: a cross sectional study. Int J Res Med Sci, 3, 3292-95.

BRICENO NORIEGA, D., ZENKER, H. E., CROES, C.-A., EWAZ, A., RUINEMANS-KOERTS, J., SAVELKOUL, H. F., VAN NEERVEN, R. J. & TEODOROWICZ, M. 2022. Receptor Mediated Effects of Advanced Glycation End Products (AGEs) on Innate and Adaptative Immunity: Relevance for Food Allergy. Nutrients, 14, 371.

BYRNE, N. J., RAJASEKARAN, N. S., ABEL, E. D. & BUGGER, H. 2021. Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy. Free Radical Biology and Medicine, 169, 317-342.

CAO, J., ZHANG, G., LIU, Z., XU, Q., LI, C., CHENG, G. & SHI, R. 2021. Peroxidasin promotes diabetic vascular endothelial dysfunction induced by advanced glycation end products via NOX2/HOCl/Akt/eNOS pathway. Redox biology, 45, 102031.

CHARLTON, A., GARZARELLA, J., JANDELEIT-DAHM, K. A. & JHA, J. C. 2020. Oxidative stress and inflammation in renal and cardiovascular complications of diabetes. Biology, 10, 18.

CORICA, D., PEPE, G., CURRÒ, M., AVERSA, T., TROPEANO, A., IENTILE, R. & WASNIEWSKA, M. 2021. Methods to investigate advanced glycation end-product and their application in clinical practice. Methods.

CUI, R., QI, Z., ZHOU, L., LI, Z., LI, Q. & ZHANG, J. 2016. Evaluation of serum lipid profile, body mass index, and waistline in Chinese patients with type 2 diabetes mellitus. Clinical interventions in aging, 11, 445.

DAI, L., WATANABE, M., QURESHI, A. R., MUKAI, H., MACHOWSKA, A., HEIMBÜRGER, O., BARANY, P., LINDHOLM, B. & STENVINKEL, P. 2019. Serum 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage, is associated with mortality independent of inflammation in chronic kidney disease. European Journal of Internal Medicine, 68, 60-65.

DARENSKAYA, M., KOLESNIKOVA, L. & KOLESNIKOV, S. 2021. Oxidative stress: pathogenetic role in diabetes mellitus and its complications and therapeutic approaches to correction. Bulletin of experimental biology and medicine, 171, 179-189.

DENG, L., DU, C., SONG, P., CHEN, T., RUI, S., ARMSTRONG, D. G. & DENG, W. 2021. The role of oxidative stress and antioxidants in diabetic wound healing. Oxidative medicine and cellular longevity, 2021.

DOBI, A., ROSANALY, S., DEVIN, A., BARET, P., MEILHAC, O., HARRY, G. J., D'HELLENCOURT, C. L. & RONDEAU, P. 2021. Advanced glycation end-products disrupt brain microvascular endothelial cell barrier: The role of mitochondria and oxidative stress. Microvascular research, 133, 104098.

DWORZAŃSKI, J., STRYCHARZ-DUDZIAK, M., KLISZCZEWSKA, E., KIEŁCZYKOWSKA, M., DWORZAŃSKA, A., DROP, B. & POLZ-DACEWICZ, M. 2020. Glutathione peroxidase (GPx) and superoxide dismutase (SOD) activity in patients with diabetes mellitus type 2 infected with Epstein-Barr virus. Plos one, 15, e0230374.

EL-MASRY, H. M. & MAHMOUD, A.-E. A. 2021. Annals of Neonatology Journal. Annals of Neonatology Journal, 3, 9-24.

EL JELLAS, K., DUŠÁTKOVÁ, P., HALDORSEN, I. S., MOLNES, J., TJORA, E., JOHANSSON, B. B., FJELD, K., JOHANSSON, S., PRŮHOVÁ, Š. & GROOP, L. 2022. Two new mutations in the CEL gene causing diabetes and hereditary pancreatitis: How to correctly identify MODY8 cases. The Journal of Clinical Endocrinology & Metabolism, 107, e1455-e1466.

FAN, L., WANG, F., YAO, Q., WU, H., WEN, F., WANG, J., LI, H. & ZHENG, N. 2021. Lactoferrin could alleviate liver injury caused by Maillard reaction products with furan ring through regulating necroptosis pathway. Food Science & Nutrition, 9, 3449-3459.

FENG, Y., FENG, Q., QU, H., SONG, X., HU, J., XU, X., ZHANG, L. & YIN, S. 2020. Stress adaptation is associated with insulin resistance in women with gestational diabetes mellitus. Nutrition & diabetes, 10, 1-4.

FISHMAN, S. L., SONMEZ, H., BASMAN, C., SINGH, V. & PORETSKY, L. 2018. The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review. Molecular Medicine, 24, 1-12.

GHEIBI, S., SAMSONOV, A. P., GHEIBI, S., VAZQUEZ, A. B. & KASHFI, K. 2020. Regulation of carbohydrate metabolism by nitric oxide and hydrogen sulfide: Implications in diabetes. Biochemical pharmacology, 176, 113819.

HAJAM, Y. A., RANI, R., GANIE, S. Y., SHEIKH, T. A., JAVAID, D., QADRI, S. S., PRAMODH, S., ALSULIMANI, A., ALKHANANI, M. F. & HARAKEH, S. 2022. Oxidative stress in human pathology and aging: molecular mechanisms and perspectives. Cells, 11, 552.

IACOBINI, C., VITALE, M., PESCE, C., PUGLIESE, G. & MENINI, S. 2021. Diabetic complications and oxidative stress: A 20-year voyage back in time and back to the future. Antioxidants, 10, 727.

ISLAM, M. A., AMIN, M. N., SIDDIQUI, S. A., HOSSAIN, M. P., SULTANA, F. & KABIR, M. R. 2019. Trans fatty acids and lipid profile: A serious risk factor to cardiovascular disease, cancer and diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 13, 1643-1647.

ITO, F., SONO, Y. & ITO, T. 2019. Measurement and clinical significance of lipid peroxidation as a biomarker of oxidative stress: oxidative stress in diabetes, atherosclerosis, and chronic inflammation. Antioxidants, 8, 72.

JEBUR, A., MOKHAMER, M. & EL-DEMERDASH, F. 2016. A review on oxidative stress and role of antioxidants in diabetes mellitus. Austin Endocrinol Diabetes Case Rep, 1, 1006-1011.

JUD, P. & SOURIJ, H. 2019. Therapeutic options to reduce advanced glycation end products in patients with diabetes mellitus: A review. Diabetes research and clinical practice, 148, 54-63.

KAMIL KADHIM LAWI, Z., AMEEN MERZA, F., RABEEA BANOON, S., AL-SAADY, M. A. A. J. & AL-ABBOODI, A. 2021. Mechanisms of Antioxidant Actions and their Role in many Human Diseases: A Review. Journal of Chemical Health Risks, 11, 45-57.

KHALILI, F., VAISI‐RAYGANI, A., SHAKIBA, E., KOHSARI, M., DEHBANI, M., NASERI, R., ASADI, S., RAHIMI, Z., RAHIMI, M. & RAHIMI, Z. 2022. Oxidative stress parameters and keap 1 variants in T2DM: Association with T2DM, diabetic neuropathy, diabetic retinopathy, and obesity. Journal of clinical laboratory analysis, 36, e24163.

KORAC, B., KALEZIC, A., PEKOVIC-VAUGHAN, V., KORAC, A. & JANKOVIC, A. 2021. Redox changes in obesity, metabolic syndrome, and diabetes. Redox Biology, 42, 101887.

LEGIAWATI, L., BRAMONO, K., INDRIATMI, W., YUNIR, E., SETIATI, S., JUSMAN, S. W. A., PURWANINGSIH, E. H., WIBOWO, H. & DANARTI, R. 2020. Oral and Topical Centella asiatica in Type 2 Diabetes Mellitus Patients with Dry Skin: A Three-Arm Prospective Randomized Double-Blind Controlled Trial. Evidence-based Complementary and Alternative Medicine, 2020.

LI, A., YI, B., LIU, Y., WANG, J., DAI, Q., HUANG, Y., LI, Y. C. & ZHANG, H. 2019. Urinary NGAL and RBP are biomarkers of normoalbuminuric renal insufficiency in type 2 diabetes mellitus. Journal of immunology research, 2019.

LI, Q., LI, L., ZHU, H., YANG, F., XIAO, K., ZHANG, L., ZHANG, M., PENG, Y., WANG, C. & LI, D. 2022. Lactobacillus fermentum as a new inhibitor to control advanced glycation end-product formation during vinegar fermentation. Food Science and Human Wellness, 11, 1409-1418.

LING, P., SHAN, W., ZHAI, G., QIU, C., LIU, Y., XU, Y. & YANG, X. 2020. Association between glutathione peroxidase‐3 activity and carotid atherosclerosis in patients with type 2 diabetes mellitus. Brain and Behavior, 10, e01773.

LUC, K., SCHRAMM-LUC, A., GUZIK, T. & MIKOLAJCZYK, T. 2019. Oxidative stress and inflammatory markers in prediabetes and diabetes. J. Physiol. Pharmacol, 70, 111-13.

MA, X., GONG, H., OGINO, K., YAN, X. & XING, R. 2022. Coordination-assembled myricetin nanoarchitectonics for sustainably scavenging free radicals. Beilstein journal of nanotechnology, 13, 284-291.

MICHALAK, M. 2022. Plant-derived antioxidants: Significance in skin health and the ageing process. International journal of molecular sciences, 23, 585.

MIROŃCZUK-CHODAKOWSKA, I., WITKOWSKA, A. M. & ZUJKO, M. E. 2018. Endogenous non-enzymatic antioxidants in the human body. Advances in medical sciences, 63, 68-78.

MOGALE, M. A., MHLANGA, C. M., GOLOLO, S. S. & ADU, A. 2019. Ellisras Longitudinal Study 2017: elevated serum levels of carboxymethyl-lysine, an advanced glycation end-product, are associated with higher odds of developing endothelial dysfunction in black South African patients with type 2 diabetes mellitus (ELS 29). South African Journal of Diabetes and Vascular Disease, 16, 57-61.

MORIDI, H., KARIMI, J., SHEIKH, N., GOODARZI, M. T., SAIDIJAM, M., YADEGARAZARI, R., KHAZAEI, M., KHODADADI, I., TAVILANI, H. & PIRI, H. 2015. Resveratrol-dependent down-regulation of receptor for advanced glycation end-products and oxidative stress in kidney of rats with diabetes. International journal of endocrinology and metabolism, 13.

NAKANO, M., NAKAMURA, Y., SUZUKI, T., MIYAZAKI, A., TAKAHASHI, J., SAITO, M. & SHIRAKI, M. 2020. Pentosidine and carboxymethyl-lysine associate differently with prevalent osteoporotic vertebral fracture and various bone markers. Scientific reports, 10, 1-11.

OKDAHL, T. & BROCK, C. 2021. Molecular aspects in the potential of vitamins and supplements for treating diabetic neuropathy. Current Diabetes Reports, 21, 1-11.

ONYIBE, P. N., EDO, G. I., NWOSU, L. C. & OZGOR, E. 2021. Effects of vernonia amygdalina fractionate on glutathione reductase and glutathione-S-transferase on alloxan induced diabetes wistar rat. Biocatalysis and Agricultural Biotechnology, 36, 102118.

PANAHI, Y., KHALILI, N., SAHEBI, E., NAMAZI, S., REINER, Ž., MAJEED, M. & SAHEBKAR, A. 2017. Curcuminoids modify lipid profile in type 2 diabetes mellitus: a randomized controlled trial. Complementary therapies in medicine, 33, 1-5.

PARCHETA, M., ŚWISŁOCKA, R., ORZECHOWSKA, S., AKIMOWICZ, M., CHOIŃSKA, R. & LEWANDOWSKI, W. 2021. Recent developments in effective antioxidants: The structure and antioxidant properties. Materials, 14, 1984.

PICKERING, R. J., ROSADO, C. J., SHARMA, A., BUKSH, S., TATE, M. & DE HAAN, J. B. 2018. Recent novel approaches to limit oxidative stress and inflammation in diabetic complications. Clinical & translational immunology, 7, e1016.

PINTO, R. S., MINANNI, C. A., DE ARAÚJO LIRA, A. L. & PASSARELLI, M. 2022. Advanced Glycation End Products: A Sweet Flavor That Embitters Cardiovascular Disease. International Journal of Molecular Sciences, 23, 2404.

PLEMMENOS, G. & PIPERI, C. 2022. Pathogenic Molecular Mechanisms in Periodontitis and Peri-Implantitis: Role of Advanced Glycation End Products. Life, 12, 218.

PORETSKY, L. 2010. Principles of diabetes mellitus, Springer.

RAMASAMY, R., SHEKHTMAN, A. & SCHMIDT, A. M. 2016. The multiple faces of RAGE–opportunities for therapeutic intervention in aging and chronic disease. Expert opinion on therapeutic targets, 20, 431-446.

REYAZ, A., ALAM, S., CHANDRA, K., KOHLI, S. & AGARWAL, S. 2020. Methylglyoxal and soluble RAGE in type 2 diabetes mellitus: Association with oxidative stress. Journal of Diabetes & Metabolic Disorders, 19, 515-521.

RUNGRATANAWANICH, W., QU, Y., WANG, X., ESSA, M. M. & SONG, B.-J. 2021. Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury. Experimental & molecular medicine, 53, 168-188.

SELLEGOUNDER, D., ZAFARI, P., RAJABINEJAD, M., TAGHADOSI, M. & KAPAHI, P. 2021. Advanced glycation end products (AGEs) and its receptor, RAGE, modulate age-dependent COVID-19 morbidity and mortality. A review and hypothesis. International immunopharmacology, 98, 107806.

SERVEAUX-DANCER, M., JABAUDON, M., CREVEAUX, I., BELVILLE, C., BLONDONNET, R., GROSS, C., CONSTANTIN, J.-M., BLANCHON, L. & SAPIN, V. 2019. Pathological implications of receptor for advanced glycation end-product (AGER) gene polymorphism. Disease markers, 2019.

SHEN, C.-Y., LU, C.-H., WU, C.-H., LI, K.-J., KUO, Y.-M., HSIEH, S.-C. & YU, C.-L. 2020. The development of maillard reaction, and advanced glycation end product (AGE)-receptor for AGE (RAGE) signaling inhibitors as novel therapeutic strategies for patients with AGE-related diseases. Molecules, 25, 5591.

SHI, L., LU, P.-P., DAI, G.-C., LI, Y.-J. & RUI, Y.-F. 2021. Advanced glycation end productions and tendon stem/progenitor cells in pathogenesis of diabetic tendinopathy. World Journal of Stem Cells, 13, 1338.

SONG, Q., LIU, J., DONG, L., WANG, X. & ZHANG, X. 2021. Novel advances in inhibiting advanced glycation end product formation using natural compounds. Biomedicine & Pharmacotherapy, 140, 111750.

SUN, J., WANG, H. J., YU, J., LI, T. & HAN, Y. 2020. Protective effect of celastrol on type 2 diabetes mellitus with nonalcoholic fatty liver disease in mice. Food Science & Nutrition, 8, 6207-6216.

TAN, S. M. Q., CHIEW, Y., AHMAD, B. & KADIR, K. A. 2018. Tocotrienol-rich vitamin E from palm oil (tocovid) and its effects in diabetes and diabetic nephropathy: a pilot phase II clinical trial. Nutrients, 10, 1315.

TSAI, K.-F., CHEN, Y.-L., CHIOU, T. T.-Y., CHU, T.-H., LI, L.-C., NG, H.-Y., LEE, W.-C. & LEE, C.-T. 2021. Emergence of SGLT2 inhibitors as powerful antioxidants in human diseases. Antioxidants, 10, 1166.

UMMAIYA, F., HARDIANTI, W., ARYO, D. P., VERONICA, E. & SUGIRITAMA, I. W. POTENTIAL OF BROCCOLI (Brassica Oleracea L. Var italica) EXTRACT AGAINST THE REDUCTION OF MDA LEVELS IN DIABETES MELLITUS TYPE II.

WANG, H., LI, N., CHIVESE, T., WERFALLI, M., SUN, H., YUEN, L., HOEGFELDT, C. A., POWE, C. E., IMMANUEL, J. & KARURANGA, S. 2022. IDF diabetes atlas: estimation of global and regional gestational diabetes mellitus prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group’s Criteria. Diabetes Research and Clinical Practice, 183, 109050.

WANG, P., CHIN, E. K. & ALMEIDA, D. 2021. Antioxidants for the treatment of retinal disease: summary of recent evidence. Clinical Ophthalmology (Auckland, NZ), 15, 1621.

WANG, Z., BAO, Z., DING, Y., XU, S., DU, R., YAN, J., LI, L., SUN, Z., SHAO, C. & GU, W. 2019. Nε-carboxymethyl-lysine-induced PI3K/Akt signaling inhibition promotes foam cell apoptosis and atherosclerosis progression. Biomedicine & Pharmacotherapy, 115, 108880.

YUAN, T., YANG, T., CHEN, H., FU, D., HU, Y., WANG, J., YUAN, Q., YU, H., XU, W. & XIE, X. 2019. New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis. Redox biology, 20, 247-260.

ZAREI, P., REZVANFAR, M. R., ANSARIHADIPOUR, H., DELAVAR, M., ABDOLLAHI, M. & KHOSROWBEYGI, A. 2018. Effects of coenzyme Q10 supplementation on the serum levels of amylase, adenosine deaminase, catalase, and total antioxidant capacity in women with type 2 diabetes mellitus: A randomized, double-blind placebo-controlled trial. Journal of Research in Medical Sciences: The Official Journal of Isfahan University of Medical Sciences, 23.